Heat Shock–Related Protein 20 Peptide Decreases Human Airway Constriction Downstream of β2-Adrenergic Receptor
Autor: | Dawn C. Newcomb, Kasia Goleniewska, Alex Banathy, Padmini Komalavilas, R. Stokes Peebles, Kelly L. Boyd, Joyce Cheung-Flynn |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Muscle Relaxation Sus scrofa Clinical Biochemistry Peptide Mice 0302 clinical medicine Adrenergic beta-2 Receptor Antagonists Cell Movement Stress Fibers Receptor Lung Original Research chemistry.chemical_classification biology respiratory system Constriction Cell biology Muscle relaxation Bronchial Hyperreactivity medicine.symptom Muscle Contraction Pulmonary and Respiratory Medicine Ovalbumin Myocytes Smooth Muscle Inflammation Filamentous actin 03 medical and health sciences otorhinolaryngologic diseases medicine Animals Humans HSP20 Heat-Shock Proteins Molecular Biology Actin business.industry Muscle Smooth Cell Biology Allergens Actin cytoskeleton Actins respiratory tract diseases 030104 developmental biology 030228 respiratory system chemistry Immunology biology.protein Carbachol Receptors Adrenergic beta-2 Peptides business |
Zdroj: | American Journal of Respiratory Cell and Molecular Biology. 55:225-233 |
ISSN: | 1535-4989 1044-1549 |
DOI: | 10.1165/rcmb.2015-0139oc |
Popis: | Severe bronchospasm refractory to β-agonists is a challenging aspect of asthma therapy, and novel therapeutics are needed. β-agonist-induced airway smooth muscle (ASM) relaxation is associated with increases in the phosphorylation of the small heat shock-related protein (HSP) 20. We hypothesized that a transducible phosphopeptide mimetic of HSP20 (P20 peptide) causes relaxation of human ASM (HASM) by interacting with target(s) downstream of the β2-adrenergic receptor (β2AR) pathway. The effect of the P20 peptide on ASM contractility was determined in human and porcine ASM using a muscle bath. The effect of the P20 peptide on filamentous actin dynamics and migration was examined in intact porcine ASM and cultured primary HASM cells. The efficacy of the P20 peptide in vivo on airway hyperresponsiveness (AHR) was determined in an ovalbumin (OVA) sensitization and challenge murine model of allergic airway inflammation. P20 peptide caused dose-dependent relaxation of carbachol-precontracted ASM and blocked carbachol-induced contraction. The β2AR inhibitor, (±)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol hydrochloride (ICI 118,551), abrogated isoproterenol but not P20 peptide-mediated relaxation. The P20 peptide decreased filamentous actin levels in intact ASM, disrupted stress fibers, and inhibited platelet-derived growth factor-induced migration of HASM cells. The P20 peptide treatment reduced methacholine-induced AHR in OVA mice without affecting the inflammatory response. These results suggest that the P20 peptide decreased airway constriction and disrupted stress fibers through regulation of the actin cytoskeleton downstream of β2AR. Thus, the P20 peptide may be a potential therapeutic for asthma refractory to β-agonists. |
Databáze: | OpenAIRE |
Externí odkaz: |